BlackRock 2037 Municipal Target Term Trust (BMN)
NYSE NYSE Primary 
CXA Summary
BMN Chart
BioMarin: Acquisition Of Inozyme Brings Forth Late-Stage ERT BMN 401
BioMarin's revenue growth is strong, with Q2 2025 revenues up 16% year-over-year and full-year guidance raised to $3.125–$3.2 billion. The Inozyme acquisition brings late-stage BMN 401 for ENPP1 deficiency, with pivotal phase 3 data expected in 1H 2026 and potential first-mover advantage. Voxzogo and Palynziq continue to drive growth, with label expansions and new pipeline candidates like BMN 333 poised to further bolster its pipeline.
BMN: Tax-Free Income With Capacity To Leverage Up
BlackRock 2037 Municipal Target Term Trust offers primarily tax-free income through a diversified muni bond portfolio. BMN's modest leverage with the Fed cutting rates puts the fund in a unique position to potentially start adding further leverage. Despite a lower distribution yield compared to some muni peers, BMN has much stronger distribution coverage, suggesting a more sustainable income stream.
BlackRock 2037 Municipal Target Term Trust (BMN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has BlackRock 2037 Municipal Target Term Trust ever had a stock split?
BlackRock 2037 Municipal Target Term Trust Profile
| Capital Markets Industry | Financials Sector | John M. Perlowski CEO | NYSE Exchange | 09262G108 CUSIP |
| US Country | - Employees | 14 Nov 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Blackrock 2037 Municipal Target Term Trust is an innovative financial solution designed to cater to investors looking for stable fixed-income investment options. Launched by BlackRock, Inc., a leading global investment management corporation, this close-ended mutual fund is expertly managed by BlackRock Advisors, LLC. The fund's strategic focus is on investing in the fixed income markets, with a specific emphasis on investment-grade municipal securities. By maintaining an investment threshold that adheres to securities rated BBB- or above by S&P and Fitch, or Baa3 or above by Moody's, the trust ensures a level of security and reliability for its investors. This focus on quality and stability makes the Blackrock 2037 Municipal Target Term Trust a distinguished option for those seeking prudent investment in municipal bonds. Domiciled in the United States, the fund caters to both individual and institutional investors seeking exposure to municipal debt markets with a targeted term ending in 2037.
Products and Services
- Fixed Income Mutual Fund
The core offering of Blackrock 2037 Municipal Target Term Trust is its status as a close-ended fixed income mutual fund. This product is designed to provide investors with a stable source of income through investments in the fixed income markets, focusing on municipal bonds. The fund's strategy revolves around investing in high-quality, investment-grade municipal securities. This allows for potentially tax-free income, making it an attractive option for investors seeking to maximize their after-tax returns.
- Investment in Investment Grade Municipal Securities
A key characteristic of the Blackrock 2037 Municipal Target Term Trust is its investment in investment-grade municipal securities. By focusing on securities that achieve a rating of BBB- or above by S&P and Fitch, or Baa3 or above by Moody's, the trust prioritizes investments in bonds that meet a high credit quality standard. This approach is geared towards minimizing risk while seeking to provide returns that are consistent with the fund's income objectives. Such a strategy is well-suited for investors who are cautious about risk and seek to invest in securities with a lower likelihood of default.
Contact Information
